{
 "PrintNo":"A486","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2020-12-29T10:07:21.898651Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-01-05","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2021-01-06","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO HEALTH","Date":"2022-01-05","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":610,"Name":"Edward Braunstein","Short":"BRAUNSTEIN"},{"ID":1259,"Name":"Jonathan Jacobson","Short":"JACOBSON"}],
 "Title":"Relates to adding W-18 to the schedule of controlled substances",
 "Summary":"Adds W-18 (4-chloro-N-{1-{2-(4-nitrophenyl)ethyl}2piperidinylidene}benzenesulfonamide) to the schedule of controlled substances.",
 "LawSection":"Public Health Law","LawCode":"Amd ยง3306, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to adding W-18 to the schedule of controlled substances",
 "SameAsPrintNo":"S1774-2021","PreviousVersions":["A3030-2017","A509-2019"]
}